Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Annals of the Rheumatic Diseases|January 7, 2006
Safety of extended treatment with anakinra in patients with rheumatoid arthritisR M Fleischmann, J Tesser, M H Schiff, et al.
The New England Journal of Medicine|January 28, 1999
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexateM E Weinblatt, J M Kremer, A D Bankhurst, et al.
The American Journal of Medicine|October 30, 1987
Six-month multi-center study comparing nabumetone with naproxen in the treatment of osteoarthritisE J Pisko, B I Bockow, P Box, et al.
Annals of the Rheumatic Diseases|October 31, 2007
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitisJ C Davis, D M van der Heijde, J Braun, et al.
The New England Journal of Medicine|July 17, 1997
Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion proteinL W Moreland, S W Baumgartner, M H Schiff, et al.
The New England Journal of Medicine|November 30, 2000
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritisJ M Bathon, R W Martin, R M Fleischmann, et al.
The Journal of Rheumatology|August 24, 2000
Treatment of rheumatoid arthritis with a DR4/1 peptideE W St Clair, S B Cohen, M L Lee, et al.
Pageof 3